Accenture and Synopsys jump while Corteva plunges 84% in midday trading

  • Accenture shares surged 18% after fiscal fourth-quarter results exceeded company guidance and analyst estimates.
  • Corteva's remaining business plunged 84% after the Vylor spinoff was formally completed.
  • United Therapeutics gained 6% after a Delaware court ruled Liquidia infringed its patent.

Accenture shares soared 18% after fiscal fourth-quarter revenue and earnings exceeded expectations, while Synopsys jumped more than 8% after outlining growth targets and announcing a partnership with OpenAI. United Therapeutics gained 6% after a Delaware federal court ruled that Liquidia infringed its patent, sending Liquidia down 15%. Constellation Energy rose nearly 3% on a 20-year Amazon agreement tied to expanded generation at a Maryland nuclear plant, and McKesson climbed 4% after reaffirming fiscal 2027 earnings guidance and extending its CVS Health distribution partnership through June 2032. McCormick fell more than 2% despite beating quarterly estimates as it remains in the process of being acquired by Unilever, whose shares also dropped more than 2%. Sigma Lithium slid 16% after suspending mining and industrial production in Brazil, while Acuity Brands declined nearly 4% on weaker-than-expected forward guidance. BJ's Restaurants rose about 5% after a Mizuho upgrade, Vicor surged almost 10% after raising its revenue growth outlook, and Corteva's remaining business plunged 84% following the formal spinoff of its Vylor seed and genetic business.

本网站上的信息是使用AI生成的,我们无法保证其准确性。 请仅作为参考信息使用。